↓ Skip to main content

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial

Overview of attention for article published in Radiation Oncology, September 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
45 Mendeley